Zum Inhalt springen

Nur-Lesen-Fassung: Das Forschungsinformationssystem (FIS) ist aus Sicherheitsgründen vorübergehend durch diese Nur-Lesen-Fassung ersetzt. Alle öffentlichen Inhalte und Volltexte sind weiterhin abrufbar; Anmeldung, Bearbeitung, Einreichung und Statistiken stehen nicht zur Verfügung. Bei Fragen: fis@uni-bamberg.de

Start › Publikationen › Associations between biomarkers of inflammation and depressive symptoms : potential differences between diabetes types and symptom clusters of depression

Publikation

Associations between biomarkers of inflammation and depressive symptoms : potential differences between diabetes types and symptom clusters of depression

Herder, Christian; Zhu, Anna; Schmitt, Andreas; u. a. (2025): Associations between biomarkers of inflammation and depressive symptoms : potential differences between diabetes types and symptom clusters of depression, in: Bamberg: Otto-Friedrich-Universität, S. 1–9.

Details

Fakultät/Lehrstuhl
Autorin(nen)/Autor(en)
Herder, Christian
Zhu, Anna
Schmitt, Andreas
Spagnuolo, Maria C.
Roden, Michael
Verlagsangabe
Otto-Friedrich-Universität : Bamberg
Erscheinungsjahr
2025
Quelle/Weitere Ausgabe
Translational Psychiatry, London: Nature Publishing Group, 2025, Jg. 15, Nr. 1, 9, S. 1–9, ISSN: 2158-3188
Sprache(n)
Englisch
Lizenz
URN
Abstract

Inflammation is a probable biological pathway underlying the relationship between diabetes and depression, but data on differences between diabetes types and symptom clusters of depression are scarce. Therefore, this cross-sectional study aimed to compare associations of a multimarker panel of biomarkers of inflammation with depressive symptoms and its symptom clusters between people with type 1 diabetes (T1D) and type 2 diabetes (T2D). This cross-sectional study combined data from five studies including 1260 participants (n = 706 T1D, n = 454 T2D). Depressive symptoms were assessed using the Center for Epidemiological Studies-Depression Scale (CES-D). Serum levels of 92 biomarkers of inflammation were quantified with proximity extension assay technology. After quality control, 76 biomarkers of inflammation remained for statistical analysis. Associations between biomarkers and depressive symptom scores and clusters (cognitive-affective, somatic, anhedonia) were estimated with multivariable linear regression models. Nine biomarkers were positively associated with depressive symptoms in the total sample (CCL11/eotaxin, CCL25, CDCP1, FGF-21, IL-8, IL-10RB, IL-18, MMP-10, TNFRSF9; all p < 0.05) without interaction by diabetes type. Associations differed for eight biomarkers (pinteraction < 0.05). TNFβ was inversely associated with depressive symptoms in T1D, whereas three biomarkers (GDNF, IL-18R1, LIF-R) were positively associated with depressive symptoms in T2D. For the remaining four biomarkers (CD6, CD244, FGF-5, IFNγ) associations were not significant in either subgroup. Biomarker associations were more pronounced with somatic and anhedonia than with cognitive-affective symptoms. These results indicate that different proinflammatory pathways may contribute to depression in T1D and T2D and that there may be a symptom specificity in the link between subclinical inflammation and depression.

Freie Schlagwort(e)
Diabetes mellitus
Depression
Inflammation
DDC-Klassifikation
610 Medizin, Gesundheit
RVK-Klassifikation
YC 6800
Peer Reviewed
ja
Internationale Verbreitung
ja
Open-Access-Zeitschrift
nein
Dokumenttyp
Artikel in einer Zeitschrift / Postprint
URI
Datum der Freischaltung
02.04.2025

Permalink: https://fis.uni-bamberg.de/handle/uniba/105977 · Daten als JSON · Zitieren: BibTeX · RIS

Datenstand: 15.11.2026

Eingeschränkter Lesezugriff: Anmeldung, Bearbeitung und Einreichung sind vorübergehend deaktiviert.